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Abstract
Integrator is an RNA polymerase II (RNAPII)-associated complex that was recently identi-
fied to have a broad role in both RNA processing and transcription regulation. Importantly,
its role in human development and disease is so far largely unexplored. Here, we provide
evidence that biallelic Integrator Complex Subunit 1 (INTS1) and Subunit 8 (INTS8) gene
mutations are associated with rare recessive human neurodevelopmental syndromes.
Three unrelated individuals of Dutch ancestry showed the same homozygous truncating
INTS1 mutation. Three siblings harboured compound heterozygous INTS8 mutations.
Shared features by these six individuals are severe neurodevelopmental delay and a distinc-
tive appearance. The INTS8 family in addition presented with neuronal migration defects
(periventricular nodular heterotopia). We show that the first INTS8 mutation, a nine base-
pair deletion, leads to a protein that disrupts INT complex stability, while the second mis-
sense mutation introduces an alternative splice site leading to an unstable messenger. Cells
from patients with INTS8 mutations show increased levels of unprocessed UsnRNA, com-
patible with the INT function in the 3’-end maturation of UsnRNA, and display significant dis-
ruptions in gene expression and RNA processing. Finally, the introduction of the INTS8
deletion mutation in P19 cells using genome editing alters gene expression throughout the
course of retinoic acid-induced neural differentiation. Altogether, our results confirm the
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essential role of Integrator to transcriptome integrity and point to the requirement of the Inte-
grator complex in human brain development.
Author summary
Neurodevelopmental disorders often have a genetic cause, however the genes and the
underlying mechanisms that are involved are increasingly diverse, pointing to the complex-
ity of brain development. For normal cell function and in general for normal development,
mechanisms that regulate gene transcription into mRNA are of outermost importance as
proper spatial and temporal expression of key developmentally regulated transcripts is
essential. The Integrator complex was recently identified to have a broad role in both RNA
processing and transcription regulation. This complex is assembled from at least 14 differ-
ent subunits and several animal studies have pointed to an important role in development.
Nevertheless, studies directly demonstrating the relevance of this complex in human health
and development have been lacking until now. We show here that mutations in the Integra-
tor Complex Subunit 1 gene (INTS1) and Subunit 8 gene (INTS8) cause a severe neurodeve-
lopmental syndrome, characterized by profound intellectual disability, epilepsy, spasticity,
facial and limb dysmorphism and subtle structural brain abnormalities. While the role of
the Integrator complex in neuronal migration has recently been established, we provide
evidence that INTS8 mutations lead in vitro to instability of the complex and impaired
function. In patients cultured fibroblasts we found evidence for abnormalities in mRNA
transcription and processing. In addition, introduction of INTS8mutations in an in vitro
model of retinoic acid-induced neuronal differentiation results also in transcription alter-
ations. Altogether our results suggest an evolutionary conserved requirement of INTS1 and
INTS8 in brain development.
Introduction
Malformations of cortical development (MCD) are a group of neurodevelopmental disorders
characterized by structural brain abnormalities involving the human cerebral cortex. They
form a common cause of developmental delay and epilepsy, accounting for 3% of intellectual
disability, 25% of pediatric partial seizures, 5–15% of adult epilepsy, and 20–40% of therapy-
resistant epilepsy [1–5]. MCD are divided into three main groups, reflecting failure of either
the neurodevelopmental process of cell proliferation, neuronal migration, or post migrational
cortical organization [6]. It was anticipated that mutations in genes unique to each disorder
and to specific developmental stages would be identified. Recently, this classification has been
challenged by the discovery of mutations in genes like WDR62 and TUBA1A [1, 7, 8] that
lead to multiple malformations originating in different stages of brain development. Among
MCDs, periventricular nodular heterotopia is considered a developmental defect of neuronal
progenitors that fail to migrate from the ventricular and subventricular zone toward the upper
cortical layers during early embryogenesis or undergo premature differentiation in apparent
neuronal lineage. The most common genetic cause of periventricular nodular heterotopia is a
mutation in the FLNA gene, which is associated with normal cognitive development. Rare
gene mutations including ARFGEF2 and several rare chromosomal aberrations explain a
small proportion of syndromic periventricular nodular heterotopia, associated with other mal-
formations and/or developmental delay (for review see [6, 9]). It is rarely associated with
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cerebellar hypoplasia and microcephaly. Moreover, many cases of periventricular heterotopia
remain without molecular etiology [10].
The Integrator complex (INT) consists of at least 14 subunits and is phylogenetically con-
served among metazoans [11, 12]. Integrator associates with the C-terminal domain of the larg-
est subunit of the RNA polymerase II (RNAPII) and has a role in the regulation of gene
expression and RNA processing. It was first discovered to mediate the co-transcriptional 3’-end
processing of the U-rich small nuclear RNAs (UsnRNAs), the RNA components of the spliceo-
some [11, 13]. Recently, the scope of Integrator complex function has broadened through the
discoveries of a general role in RNAPII promoter proximal pause-release and in the processing
of enhancer RNAs [14–18]. Most Integrator complex subunits bear no homology to any RNA
processing machinery or transcriptional regulators that would allow a predictable function
within the complex, with the exception of Integrator complex subunits INTS9 and INTS11 [19].
These subunits are paralogues of the cleavage and polyadenylation specificity factor subunits
CPSF100 and CPSF73 respectively, which form the endonuclease factor responsible for cleavage
of pre-mRNA at the polyA site [20–22]. Although animal studies suggest an evolutionary con-
served requirement of Integrator complex subunits for normal embryonic development [23–
28], human germline mutations have not yet been linked to disease.
Interestingly, mutations in UsnRNA have been previously linked to splicing alterations
leading to brain disorders. For example, mutations in the mouse Rnu2-8, coding for U2
snRNA, result in cerebellar degeneration [29], RNU4atac mutations in humans result in
extreme microcephaly [30] and mutations in RNU12 have been found associated with early-
onset cerebellar ataxia[31]. Recently, mutations in the non-canonical deadenylase TOE1 that
trims the 3’ ends of pre-UsnRNA, have been linked to pontocerebellar hypoplasia[32]. More-
over, promoter-proximal pausing, affecting up to 40% of the genes, is particularly important
during development [33, 34]. Paused RNAPII is preferentially encountered at developmen-
tally-regulated genes where it can orchestrate the synchronous gene activation necessary for
pattern formation [35–38]. This process is particularly important during neuronal develop-
ment, synapse plasticity and maturation [39–41]. Altogether, these data indicate that, through
UsnRNA processing and RNAPII promoter-proximal pausing, reduced Integrator activity
could have an impact on normal human neurodevelopment.
Here, we describe the first report of INT mutations that are associated with severe neurode-
velopmental defects. We identified mutations in two distinct INT subunits, INTS1 and INTS8,
which are present in six patients from four unrelated families. We determined that patients
with INTS8mutations carry two distinct alleles where one leads to the production of an unsta-
ble transcript while the other deletes three conserved amino acids near the C-terminus that
disrupts integrity of the whole complex. We detect significant splicing and transcriptional
defects in patients cells and demonstrate that replacement of intact INTS8 genes with the dele-
tion mutant using genome editing is sufficient to disrupt retinoic-acid induced neuronal dif-
ferentiation in P19 cells.
Results
Biallelic INTS1 and INTS8 mutations
In our research cohort of patients with brain abnormalities we identified six individuals from
four families with a distinct and recognizable neurodevelopmental syndrome. Clinical details
are presented in Table 1. In summary, all patients shared profound intellectual disability, lack
of speech development, motor impairment, seizures and similar dysmorphic features of the
face and limbs. In addition, the three individuals from the same sibship had severe spastic tet-
raplegia, borderline microcephaly, and an abnormality at brain MRI: cerebellar hypoplasia,
Integrator complex mutations and brain development
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reduced volume of pons and brainstem and periventricular nodular heterotopia (PNH), a
migration defect of the cortical neurons (Fig 1A–1F).
Two of the other unrelated individuals of Dutch ancestry sharing a similar phenotype un-
derwent exome sequencing for clinical diagnostic purposes. In both patients the same homo-
zygous nonsense mutation in INTS1was found c.5351C>A, p.(Ser1784), (NM_001080453),
whereas all the parents were heterozygote for the mutation. The last individual of Dutch ances-
try was diagnosed because of recognizable dysmorphic features and was found by targeted
analysis to be homozygote for the p.(Ser1784) mutation, while his parents were heterozygotes.
Additional genomic analysis, using Illumina Infinium_CytoSNP_850K v1.1 genotyping array,
was performed which showed in all three individuals a shared region of homozygosity (accord-
ing to UCSC Genome Browser Mar. 2009 (NCBI37/hg19)), suggesting this mutation was de-
rived from a common ancestor. This mutation is not reported in ExAC (http://exac.broad
institute.org), nor in gnomAD databases (http://gnomad.broadinstitute.org/). Expression of
Table 1. Clinical phenotype of human INTS1 and INTS8 mutations.
INTS8 patient 1 INTS8 patient 2 INTS8 patient 3 INTS1 patient 1 INTS1 patient 2 INTS1 patient 3
Type of
mutation
c.893A>G, p.
Asp298Gly;
c.2917_2925del, p.
Glu972_Leu974del
c.893A>G, p.
Asp298Gly;
c.2917_2925del, p.
Glu972_Leu974del
c.893A>G,p.
Asp298Gly;
c.2917_2925del, p.
Glu972_Leu974del
c.5351C>A, p.
(Ser1784*),
homozygote
c.5351C>A, p.
(Ser1784*),
homozygote
c.5351C>A, p.
(Ser1784*),
homozygote
Age at last
observation
35 yr 32 yr 30yr 9 yr 19 yr 6 yr
Gender male female male female male male
Growth
parameters
stature nd -2 SD -2 SD -3 SD - 4 SD - 3 SD
head
circumference
-3 SD -2 SD -2.5 SD 0 SD 0 SD 0 SD
Neurology
Cognitive delay severe severe severe Moderate/severe severe severe
Language
development
no no no no no no
Motor
impairment
Non ambulant, spastic
paraplegia
Non ambulant, spastic
paraplegia
Non ambulant, spastic
paraplegia
Walks with aid Walks with aid Non ambulant
Seizures yes yes yes yes no no
Brain MRI scan Cerebellar hypoplasia,
Nodular heterotopia
Cerebellar hypoplasia,
nodular heterotopia
Cerebellar hypoplasia,
nodular heterotopia
Hypoplastic
cerebellar inferior
vermis
Normal normal
Congenital
abnormalities
Face Prominent glabella Prominent glabella,
hypertelorism
Prominent glabella,
hypertelorism
Frontal bossing,
hypertelorism,
dolicocephaly
Frontal bossing,
hypertelorism,
dolicocephaly, cleft
lip and palate
Frontal bossing,
hypertelorism,
dolicocephaly
Skeletal/Limbs Irregularly implanted
and overlapping toes
Irregularly implanted
and overlapping toes
Irregularly implanted
and overlapping toes
Pectus
abnormality,
Irregularly
implanted and
overlapping toes
Pectus
abnormality,
Irregularly
implanted and
overlapping toes
Pectus
abnormality,
Irregularly
implanted and
overlapping toes
Visceral organs normal normal normal normal Renal dysplasia Congenital heart
defect
Vision No visual contact Optic atrophy Optic atrophy cataract cataract cataract
https://doi.org/10.1371/journal.pgen.1006809.t001
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mRNA bearing the p.Ser1784 mutation in skin fibroblasts derived from two patients was sig-
nificantly reduced when tested by qRT-PCR (S1 Fig), compatible with a loss of function effect.
Whole genome sequencing (WGS) using DNA from the three affected siblings and three
unaffected family members identified biallelic mutations in the Integrator Complex subunit 8
gene (INTS8) in the affected individuals, following an autosomal recessive inheritance pattern
(Fig 1G, S1 and S2 Tables). The first mutation is a predicted missense mutation (c.893A>G, p.
Asp298Gly), and the second is an in-frame nine-base-pair deletion leading to the deletion of
three amino acids (c.2917_2925del, p.Glu972_Leu974del; simplified as INTS8ΔEVL in the rest
of the text) (Fig 1H). Both mutations are not reported in either the ExAC or the gnomAD data-
bases. The mutations and their segregation in the family were confirmed by Sanger sequencing
(Fig 1I–1L). Interestingly, the c.893A>G mutation arose de novo in the father. INTS8 is a
995-amino-acid protein, containing four predicted tetratricopeptide (TPR) motifs, which are
Fig 1. Biallelic INTS8 mutations in a family with a severe neurodevelopmental syndrome. (A-C) Magnetic resonance imaging (MRI) of affected
individual III-2 showing cerebellar hypoplasia (A,C, arrow), reduced volume of the pons and brainstem and periventricular nodular heterotopia (B, arrows)
versus (D-F) normal MRI from unaffected individual. (G) Pedigree of the extended family; filled symbols represent affected individuals. Below each
individual the INTS8 alleles (wt = wild type) are shown. (H) Schematic of INTS8 including the four tetratricopeptide (TPR) motifs (blue blocks), the patient
mutations and in the lower panel the conservation of the affected amino acids residues throughout evolution. (I-L) Electropherograms from Sanger
sequencing of INTS8 wild type and mutant alleles.
https://doi.org/10.1371/journal.pgen.1006809.g001
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versatile protein-protein interaction domains. Both mutations reside in conserved regions of
the protein and INTS8ΔEVL is located at the C-terminus of the TPR4 domain in a predicted
alpha helix (Fig 1H). In spite of sequencing INTS8 in 25 PNH patients and 266 other patients
with brain malformations, we did not observe additional biallelic INTS8mutations, which sug-
gests that INTS8mutational rate is very low. This is supported by the high combined annota-
tion dependent depletion (CADD) score of the mutations (S3 Table) [42] and, with a score of
0.99, being classified as an extremely “loss-of-function intolerant” gene in the ExAC database
(http://exac.broadinstitute.org).
INTS8 c.893A>G mutation
To study whether and how these mutations affect INTS8 expression we cultured cell lines from
primary fibroblasts from the three affected siblings and their unaffected brother, who is hetero-
zygous only for the INTSΔEVLmutation. qRT-PCR analysis indicates that INTS8 expression is
reduced in patient cells (~50% reduction) suggesting that one of the mutant INTS8 alleles is
not expressed (Fig 2A). To test this possibility, we designed a different set of primers incapable
of amplifying the INTS8ΔEVL allele and found that the expression of the INTS8 c.893A>G
allele is almost undetectable in patients (Fig 2A).
Close analysis of known INTS8 transcripts in the NCBI RefSeq database indicates that the
INTS8 c.893A>G mutation is located at position +1 of the exon 8 of an annotated alternative
30 splice site used in isoform NR_073445.1 (variant 3, Fig 2B). This variant is predicted to gen-
erate a premature stop codon within exon 8 and to be subjected to rapid degradation through
nonsense mediated decay (NMD). To test the impact of c.893A>G on exon 8 splicing, we
designed an INTS8-GFP minigene-reporter construct (Fig 2C). Wild-type-INTS8minigenes
transfected into HeLa or HEK293T cells generated two distinct exon inclusion products (Fig
2D, lane 2 and 5), confirmed by Sanger sequencing to be variants 1 and 3 (S2A and S2B Fig).
Strikingly, introduction of the single base c.893A>G mutation into the INTS8 reporter was
sufficient to change the splicing of exon 8 so that the distal 30 splice site used in the INTS8 vari-
ant 3 was now exclusively utilized (Fig 2D, lane 3 and 6). Cloning and sequencing of this single
spliced product confirmed the predicted exon junction (S2C Fig). Both endogenous isoforms
can be detected in HeLa cells but variant 3 constitutes only 6% of total cellular INTS8mRNA
(S2D and S2E Fig). Treatment of HeLa or HEK293T cells with puromycin or cycloheximide
increased variant 3 RNA levels to 43% and 34%, respectively (S2E Fig), which indicates that
variant 3 is subject to rapid degradation, probably through NMD [43]. Similarly, baseline levels
of INTS8 variant 3 in patient cells are also increased after mRNA stabilization by puromycin or
cycloheximide treatment (S2F Fig). Collectively, these results show that the c.893A>G muta-
tion dramatically alters the splicing of INTS8 exon 8, producing a premature stop codon and
an unstable transcript.
INTS8 c.2917_2925del mutation
As the c.893A>G allele produces an unstable mRNA, we deduced that the mutant INTS8ΔEVL
is the preponderant protein expressed as suggested by the levels of mRNA expression in patient
cells (Fig 2A, middle panel). Therefore, we investigated whether the INTS8ΔEVL protein could
impact INTS8 interaction with the other subunits in the complex. To that end, we established
HEK293T cells stably expressing wild-type (WT) or mutant (ΔEVL) INTS8 bearing an N-termi-
nal 3XFLAG tag and purified the associated complex using anti-FLAG affinity resin. WT and
mutant INTS8-associated peptides showed a very similar pattern by SDS-PAGE (S3 Fig). Prob-
ing for the presence of specific Integrator complex subunits by western blot revealed however
differential association with the two proteins. The FLAG-INTS8-ΔEVL eluates contained nearly
Integrator complex mutations and brain development
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Fig 2. Characterization of the INTS8 mutations. (A) qRT-PCR on fibroblast-derived RNA of the patients (III-2, III-3, III-4), their unaffected sibling (III-1),
and two age-matched control cell lines (C1, C2), normalized for GAPDH expression. Expression of the c.893A>G allele vs. wild type was measured using a
primer located at the c.2917-2925del locus (INTS8 non-ΔEVL allele). (B) Schematic overview of INTS8 genomic and protein sequence. The c.893A>G
mutation (in red) is located at the 5’ end of the exon8 of the transcript variant 3 that contains a premature stop codon (PTC). (C) Schematic of the GFP-
minigene reporter construct used to evaluate the effect of the c.893A>G mutation on INTS8 exon 8 splicing pattern. Size of the corresponding amplicons is
indicated on the left (D) RT-PCR analysis of RNA isolated from HeLa (lanes 1–3) or HEK293T cells (lanes 4–6) transfected with the GFP-minigene
constructs. The empty reporter (GFP) is used as a control. (E) Western blot analysis of flag-affinity eluates from HEK293T stable lines expressing 3xFlag-
tagged INTS8 wild type (WT) or INTS8ΔEVL. (F) Western blots on total cell extracts from patient and control primary fibroblasts. (G) qRT-PCR showing
Integrator complex mutations and brain development
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undetectable amounts of INTS1,-12 and RPB1, reduced levels of associated INTS4, -9 and -11,
but similar levels of INTS5 and INTS3, compared to FLAG-INTS8–WT (Fig 2E). Thus, the
ΔEVL mutation appears to impact the ability of INTS8 to associate with selected members of
the Integrator complex. In patient cells, we found slightly reduced levels of several INT subunits
including INTS3, INTS5, INTS11 and INTS12 (Fig 2F). We also observed significantly reduced
levels of INTS4 and INTS9 (Fig 2F). The reduction in quantity of several INT subunits could be
due to reduced mRNA expression or protein accumulation suggesting that the reduced associa-
tion of INTS8 with certain members of Integrator complex could lead to an overall loss in the
protein complex integrity and affect in return the stability of some of its subunits. Consistent
with this observation, we measured slight but significantly elevated amounts of misprocessed
UsnRNA in patient cells (Fig 2G), while total UsnRNA levels did not significantly differ between
patient and control cells (S4 Fig). Taken together, these results indicate that the INTS8muta-
tions lead to both a reduction in integrity and function of the Integrator complex.
Alteration of gene expression and splicing patterns genome wide
To investigate the extent of INTS8dysfunction on transcription and splicing, we conducted both
exon array analysis and RNA-seq on patient cells relative to controls. Differential gene expression
(DGE) data from exon arrays performed on fibroblasts showed a large number of significantly
dysregulated genes, including INTS8, in the patient vs. control cells (n = 682; p<0.02, S4 Table).
To confirm both the results and the reproducibility attained by exon array we selected four of the
highly dysregulated genes that are also known to be expressed in brain and important in CNS
development and tested their expression using qRT-PCR. Importantly, we were able to success-
fully confirm the results using two independent qRT-PCR experiments comparing the three
patients with two new and independent age-matched fibroblast control cell lines (S5 Fig). To fur-
ther explore a genome-wide effect on splicing we subjected poly(A) mRNA fractions from patient
III-2 and III-4 and 2 age-matched controls to high depth RNA-seq analysis (~65-fold average cov-
erage, S5 Table). We found an even larger number of genes (N = 3,002; p<0.02) that were signifi-
cantly up- or downregulated in patient cells vs. control cells (S6 Table). We validated 17 of these
potential target genes by qRT-PCR (illustrative examples are in Fig 3A and 3B, S6 Fig). Compari-
son of DGE data between exon arrays and RNA-seq showed a correlation coefficient of 0.66
between the two data sets (Fig 3C) and, interestingly, that a majority of the genes that are signifi-
cantly dysregulated in both datasets (N = 82) are expressed in the CNS (S7 Table).
In addition to transcriptional deregulation, we also detected significant splicing changes in
215 genes (p<0.01, 292 total events, S8 Table) and confirmed the INTS8 alternative splicing
induced by the c. 893A>G mutation in patient cells. The vast majority of affected splicing
events are skipped exons (65%) and mutually exclusive exons (19%, Fig 3D). We selected four
alternatively spliced genes and confirmed the corresponding splicing changes using RT-PCR
assays with primers flanking differentially spliced regions (Fig 3E and 3F, S7 Fig). Altogether,
these multiple analyses demonstrate broad changes in both splicing and transcript levels in
patient cells containing disrupted INTS8 expression.
INTS8 expression during mouse and human fetal brain development
In situ hybridization (ISH) data in mouse embryonic brain show a high expression of INTS8 in
the CNS at E14.5, especially in the brain cortex ventricular zone (VZ) and hindbrain (S8 Fig)
normalized expression of misprocessed U1, U2 and U4 snRNAs in total RNA extracted from patient III-2 and III-4 fibroblasts compared to two controls. All
pairwise comparisons between patient and control UsnRNA levels are significant (at least p<0.05, Student’s T-test) to the exception of III-2 and C1 for
UsnRNA U1 (p<0.06).
https://doi.org/10.1371/journal.pgen.1006809.g002
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[44]. In humans, heat maps extracted from expression array data of several brain areas show
high expression of INTS8 in the ventricular and subventricular zones, caudal and lateral gan-
glionic eminences and cerebellar primordium at 16–21 postconceptional week (pcw) (S8 Fig).
In the first and second trimester, from the ganglionic eminences, GABAergic interneuron pro-
genitors migrate tangentially in the subventricular and marginal zone of the telencephalon in
order to organize cortical development; meanwhile the subventricular zone is also an area of
active proliferation of glutamatergic neural progenitors [45]. Analysis with the R software of
raw RNAseq data of INTS8 expression at several developmental stages (range 8 pcw—40 years)
across different human brain areas and multiple individuals, obtained from BrainSpan, shows
Fig 3. Dysregulated transcriptome in patient skin fibroblasts. (A, B) qRT-PCR validation of gene expression
variation in patient cells for two illustrative examples, NPTX1 and OSR2 mRNAs. (C) Correlation analysis of differential
gene expression data from exon arrays (X axis) and RNA-seq (Y axis). (D) Pie chart representing the different types of
alternative splicing events detected in patient cells vs control in RNA-seq data (n = 215, p<0.01, 292 total events). (E, F)
Experimental verification by RT-PCR of the splicing changes associated with INTS8 mutations for two illustrative
examples ADAM15 (E) and ATL3 (F) mRNAs.
https://doi.org/10.1371/journal.pgen.1006809.g003
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that INTS8 expression peaks during early embryonic development, and decreases to retain a
stable level during postnatal life (S9 Fig). The spatiotemporal expression pattern of INTS8 sug-
gests co-localization with both pyramidal and interneuron progenitors regulating neuronal
migration and is in accordance with the PNH phenotype.
In vitro differentiation of INTS8ΔEVL mutant cell
To investigate whether the INTS8ΔEVLmutation could have an impact on neuron differentia-
tion we used CRISPR/Cas9-mediated genome editing to introduce a homozygous EVL dele-
tion in mouse P19 pluripotent embryonic carcinoma cells (Fig 4A). After recombination,
clonal selection and screening, we retained two lines bearing homozygous INTS8ΔEVLmuta-
tions (ΔEVLA and ΔEVLB). Similarly to what we observed in fibroblast cells from patients,
western blot analysis of Integrator complex subunits shows that expression levels of several
subunits are reduced in the mutant cell lines compared to the parental line (Fig 4B), indicating
that introduction of the ΔEVL mutation into INTS8 is sufficient to disrupt accumulation of
other members of INT. Additionally, we could also detect significant levels of U11 and U12
misprocessed snRNA in mutant cells indicating that not only is the integrity of INT disrupted
in these cells but also its function (S10 Fig).
We then used these cell lines as an in vitro model of retinoic acid (RA)-induced neuron differ-
entiation. After RA treatment, we followed by qRT-PCR the expression of different markers for
pluripotency, retinoic acid response, neuronal precursor and neuronal differentiation. While
the timing of the appearance or the morphology of differentiated neurons did not significantly
differ between the two ΔEVL mutants and the parental P19 control, we observed marked differ-
ences in gene expression over the course of the process (Fig 4C). In response to RA, the induc-
tion of hoxa1 (direct transcriptional target of RA) is markedly reduced in the mutant lines even
though rapid downregulation of pluripotency genes like Oct4 is not altered. Later on, although
not altered in its intensity, the induction of the neuronal stem cell marker nestin (nes) is tempo-
rally distinct between the control and the mutants, where its expression is delayed at first and
later on more rapidly induced than in the control line. Finally, the induction of several neuronal
markers such as tubulin beta-3 (tubb3) or reelin is reduced while others remain similar to the
control (synapsin-1, syn1). These experiments confirm that the INTS8ΔEVLmutant protein can
have a profound effect on gene expression during a neuronal differentiation process.
Discussion
The present study provides a rare insight into the effect of an Integrator complex deficiency in
humans. We identified biallelic mutations in the Integrator complex subunit INTS8 in three
siblings and in Integrator complex subunit INTS1 in three unrelated individuals with a rare
and severe developmental brain disorder and similar phenotypic abnormalities. The INTS1
mutation leads to strong reduction of its mRNA expression in skin fibroblasts. In the case of
INTS8, we show that one INTS8mutant allele leads to rapid mRNA decay while the other
translates into a protein lacking three residues in the C-terminus that impacts the overall sta-
bility of the Integrator complex. Our results indicate that Integrator-deficient patient cells con-
tain global transcriptome perturbations manifesting as both altered splicing patterns and
differential gene expression. Finally, the introduction of the INTS8ΔEVLmutation in P19
embryonic carcinoma cells also alters the pattern of differentiation marker expression during
RA-induced neuronal differentiation.
The phenotype among the individuals with INTS8 and INTS1mutations is similar, combin-
ing profound intellectual disability, epilepsy, lack of speech, facial and limb dysmorphism,
altogether forming a recognizable syndrome. In patients with INTS8mutations, it is also
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Fig 4. Effect of INTS8ΔEVL mutation on P19 cell neuronal differentiation. (A) Two P19 clonal cell lines bearing a
homozygous INTS8ΔEVL mutation were generated by CRISPR/Cas9 mediated genome editing using two different guide
RNAs. After genomic DNA extraction, the region surrounding the INTS8ΔEVL mutation is amplified by PCR and the
corresponding DNA digested with NheI to detect homologous recombination or mock digested (Unc = uncut). The P19
parental cell line is used as a control. (B) The protein expression of different INT subunits is monitored by Western Blot in
total cellular extracts of INTS8ΔEVL mutant P19 cell lines. The P19 parental cell line is used as a control. Tubulin serves as
a loading control. (C) Expression of neuronal differentiation markers during RA-induced differentiation of P19 cells. Wild-
type and INTS8ΔEVL P19 cell lines are treated with RA and let to differentiate for 8 days. Cells are harvested at the
indicated time points after the initiation of the differentiation protocol (D0 = day zero, D2 = day two, D4 = day4, D8 = day8)
and RNA was extracted and reverse transcribed. Gene expression is determined by qRT-PCR (n = 3, +/- SEM). GAPDH
expression is used as a normalizer.
https://doi.org/10.1371/journal.pgen.1006809.g004
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associated with a rare combination of structural brain malformations including PNH and cere-
bellar hypoplasia. This association of PNH, a neuron migration disorder, with an Integrator
subunit mutation is particularly interesting in view of the recent observation of a neuronal
migration defect in mouse embryonic brain after Ints1 and ints11 knock-down and could
implicate the Integrator complex function in the etiology of the disorder [46]. In spite of exten-
sive search, we did not observe additional INTS8mutations in other individuals with similar
combination of PNH and cerebellar hypoplasia, which suggests that either this association of
brain malformations is not constant in this disorder or this is an ultra-rare disorder (i.e. caused
by mutation in a gene with very low mutational rate) [47]. The fact that the other phenotypic
features are shared with the INTS1mutations supports the former, while the high CADD score
of the mutations and the very few INTS8 deleterious variants reported in control populations
support the latter (S2 Table). This also suggests that complete loss of INTS8 could be incompat-
ible with human life. The same may be true for most Integrator complex subunits as loss of
any Integrator complex component tested to date has proven lethal in various animal models
at early developmental stages [23–28]. Yet, it is intriguing that although INTS8 is ubiquitously
expressed, the brain is disproportionally affected by its disruption. Considering that INTS8
expression peaks in the developing fetal brain, these observations point to a specific role for
INTS8 and more generally for the Integrator complex during brain development.
Using in-depth analysis of genome-wide alternative exon usage we show that in patient
cells the splicing pattern of up to 215 individual genes is affected. This finding could be compati-
ble with a functional defect of the spliceosome and correlates with the increased level of mispro-
cessed UsnRNAs that we observe in patient cells. Several of these alternatively spliced genes can
be individually linked to brain-related phenotypes and could therefore individually or collec-
tively contribute to the phenotype even though no gene known to be directly involved in cortical
malformation (heterotopia, with/without cerebellar hypoplasia and microcephaly) show abnor-
mal splicing in patient fibroblasts [6]. However, among the alternatively spliced genes that we
identified SPTAN1 is of particular interest (S7 Fig). Indeed, our RNA-seq analysis indicates that
exon 37 of the gene is almost completely skipped in patient cells. Patients with SPTAN1 muta-
tions present severe intellectual disability, no visual tracking, epilepsy and spastic tetraplegia.
Brain imaging shows cerebellar hypoplasia, acquired microcephaly and hypomyelination [48].
Hence, patients with SPTAN1 mutations share many rare features with the patients described in
this study. Also RPGRIP1L, mutated in Joubert syndrome with cerebellar hypoplasia, retinal dys-
trophy and variable cortical malformation, has disrupted alternative splicing in patients with
INTS8mutations. Although we find a broad disturbance of splicing patterns, it is only specula-
tive to relate the results of individual genes in fibroblast cell lines to brain development. Numer-
ous studies have however demonstrated that the brain relies heavily on alternative splicing to
regulate neuronal development [49–54]. Moreover, spatiotemporal control of alternative splicing
is crucial in the generation and differentiation of neuronal progenitors [55]. This is supported by
the finding that mutations in the splicing factor RNA-binding motif RBM10 cause abnormal
mRNA splicing, microcephaly, PNH, and cerebellar hypoplasia [56]. In addition, alterations in
UsnRNAs have severe consequences on brain development in both mice and humans. A muta-
tion in the mouse Rnu2-8 gene, coding for U2 snRNA, results in abnormal pre-mRNA splicing
of specific transcripts and in cerebellar degeneration [29]. Similarly, mutations in the minor spli-
ceosome U4atac snRNA gene in humans result in splicing defects and the rare disorder microce-
phalic osteodysplastic primordial dwarfism type I (MOPD1) [30, 57]. Mutations in another
minor spliceosome snRNA, RNU12, result in U12-type exon retention and are associated with
cerebellar ataxia[31]. Therefore, a toxic effect of the accumulation of misprocessed UsnRNAs on
the spliceosome in response to INTS8mutations is possible and could result in the differential
splicing patterns that we observed in patient versus control cells.
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Our results show a great number of differentially expressed genes in the patient cells. Signif-
icantly and reproducibly the top dysregulated genes in exon arrays are NOG (OMIM 602991,
encoding noggin) and TUBA1B that both have a primary role in brain and development (S7
Fig). Noggin inhibits BMP4, one of the major bone morphogenic proteins required for growth
and patterning of neural tube while TUBA1B (OMIM 602530, coding for tubulin-beta) shows
its highest expression in brain and is one of the several tubulin genes essential for normal cor-
tical development in human. Tubulin-beta forms a dimer with tubulin-alpha, encoded by
TUBA1A, a gene mutated in syndromic cortical malformation with microcephaly, cerebral
and cerebellar dysgyria [7]. On a mechanistic level, the effects of INTS8mutation on gene
expression could be linked to the newly identified function of Integrator complex in the regu-
lation of RNAPII-dependent transcriptional initiation, pause-release and elongation of pro-
tein-coding genes [14, 16, 17]. This finding greatly expanded the scope of Integrator complex
function as well as its potential impact on transcription, particularly on genes known to be reg-
ulated by promoter-proximal pausing such as immediate early genes (IEGs) [14]. Moreover, at
the level of the neuron itself, promoter-proximal pausing and IEGs play an important role in
neuronal development, synapse plasticity and maturation through neuronal activity-depen-
dent transcription activation [39–41]. It is therefore possible that part of the disease pathogen-
esis associated with INTS8mutations also results from widespread transcription deregulation,
apart from abnormal splicing.
A definitive answer will require a detailed analysis of INTS8 role in neuronal differentiation
and in brain development. Our results in P19 differentiation by retinoic acid indicates that
INTS8ΔEVLmutation can indeed cause misprocessing of snRNA and can affect expression of
many differentiation-regulated genes and could therefore have consequences on neuronal and
brain development. The recent progress in genetic engineering ushered by the development of
CRISPR/Cas9-based genome editing tools will enable the development of animal models tai-
lored in the future to address these questions. Likewise, progress in cell reprogramming and
induced pluripotent cell production should allow for the direct use of patient cells to study the
impact of INTS8mutations on neuron differentiation in their original genetic background.
Our study provides the first evidence for a crucial role of the Integrator complex during
human brain development. INTS8 is essential for the structural and functional integrity of
Integrator complex, and mutated INTS8 causes increased UsnRNA misprocessing, increased
AS events and altered gene expression, confirming a central role for Integrator complex in
transcriptional regulation and, together with INTS1mutations, an unexpected role in human
brain development.
Materials and methods
Ethics statement
All study participants or their legal caretakers gave written informed consent to participate in
this study, and for publication of images, according to Erasmus MC institutional review board
requirements (protocol METC-2012387).
Genomic analysis: Whole genome sequencing, whole exome and
Sanger sequencing
Details of the Whole-genome sequencing (WGS), whole-exome sequencing (WES) and Sanger
sequencing are provided in Supplemental methods (S1 Text). Data are deposited internally at
the Erasmus MC in respect to the privacy of the families.
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qRT-PCR of endogenous INTS8
Quantitative qRT-PCR of RNA extracted from cultured fibroblasts of the affected siblings,
their unaffected brother, and two control cell lines was carried out using a KAPA SYBR FAST
qPCR Kit (Kapa Biosystems) in the CFX96 Real-Time system (BioRad). Details are provided
in S1 Text.
qRT-PCR of misprocessed UsnRNA and Integrator target gene
expression in primary fibroblasts
qRT-PCR was performed using RNA from cultured fibroblasts on a Stratagene Mx3000P real-
time PCR system (Agilent) using the KAPA SYBR FAST qPCR Kit (Kapa Biosystems) accord-
ing to manufacturer’s instructions. Details are provided in S1 Text.
Splicing assays
Exon 8 and flanking intronic sequences of human INTS8 gene were amplified from HEK293T
genomic DNA by PCR (primers in S1 Text). The amplicon was cloned into the pGint vector
[58] using BamHI and SalI restriction sites. The A893G mutation was introduced by site
directed mutagenesis (primers in S1 Text). The resulting constructs were transfected in
HEK293T and HeLa cells using Lipofectamine2000 (Thermo Fisher). After 48h, total RNA
was extracted, purified and used to generate cDNA using M-MLV reverse transcriptase
(Thermo Fisher) using manufacturer specifications. PCR amplification of the corresponding
splicing product was performed. For detection and quantification, oligonucleotides were 5’
radiolabeled using 32P-γATP and T4 Polynucleotide Kinase (Thermo Fisher) and added in a
1/10 ratio with unlabeled oligonucleotides. The corresponding PCR reactions were resolved
onto a 6% non-denaturing acrylamide gel, fixed and dried. The gels were scanned using a stor-
age phosphor screen and a Storm scanner (GE Healthcare) and quantified using ImageQuant
software (GE Healthcare).
INTS8 stable cell lines and Flag-affinity purification
The human INTS8 cDNA was amplified by PCR from HeLa cell cDNA and the corresponding
PCR product was cloned into a modified pCDNA6 plasmid containing an N-terminal 3XFlag
tag (See S1 Text). The EVL deletion was introduced by site-directed mutagenesis. HEK293T
cells were transfected with either construct. Flag-affinity purification was performed as in [11]
using nuclear extracts from approximately 109 cells. Integrator subunits in the eluate were
detected by Western blot using the following antibodies: anti-FLAG M2 (Sigma), INTS1
(Bethyl, A300-361A), INTS3 (Bethyl, A302-050A), INTS4 (Bethyl, A301-296A), INTS5
(Abcam, ab74405), INTS9 (Bethyl, A300-422A), INTS11 (Bethyl, A301-274A) and INTS12
(Proteintech, 16455-1-AP). Oligonucleotide sequences are listed in S1 Text.
Western blot of Integrator complex components
Cultured fibroblasts were used for western blots of Integrator complex components. Approxi-
mately 32 μg of the clarified whole cell extract were separated on an 8% acrylamide SDS-PAGE
gel. After transfer to a PVDF membrane, the presence of the different Integrator complex sub-
units was assessed by Western blot using the antibodies listed above.
Exon arrays
Six Affymetrix GeneChip Human Exon 1.0 arrays of RNA extracted from cultured fibroblasts
of all three affected siblings and three age and sex-matched controls were robust multi-array
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(rma) normalized on transcript level using the R package (http://www.r-project.org). Top
down- and upregulated genes with p values<0.02 were analyzed for enriched gene ontology
terms (goterms_BP_all) using DAVID (medium stringency) to identify clusters with signifi-
cant enrichment (enriched score 1.3). CEL file microarray data are available under GEO
accession number GSE48849 (http://www.ncbi.nlm.nih.gov/geo/).
RNA-Seq analysis
Poly(A) mRNA fractions isolated from cultured fibroblasts from patient III-2, III-4, and two
controls were subjected to RNA-Seq analysis. In order to detect even slight changes in splicing,
we utilized high depth RNA sequencing (S4 Table). The resulting data was analysed using a
recently developed pipeline specifically designed to monitor splicing efficiency [59]. In addi-
tion, we analysed patient and control RNA-Seq data for differences in gene expression at
steady state levels using EdgeR. Data are deposited in Gene Expression Omnibus (GSE76878).
P19 RA-induced differentiation assay
Differentiation of P19 cells was conducted according to [60]. Briefly, 107 exponentially grow-
ing cells were seeded on agarose-coated plate in a culture medium without serum containing
1μM all-trans Retinoic Acid (sigma) and N-2 supplement (Thermo Fischer). After 48h, embry-
onic bodies were collected and seeded on tissue culture plates in medium with serum. After
48h, medium was replaced with culture medium without serum containing N-2 supplement.
Half of the culture medium was replaced every 48H with fresh medium. RNA was extracted at
day0, day2, day4 and day8 using Trizol (Thermo Fisher). The mRNA expression levels of neu-
ronal differentiation markers were monitored by qRT-PCR (see S1 Text for details).
CRISPR/Cas9-mediated genome editing in P19 cells
Genome editing was conducted as in [61] with minor variations. See S1 Text for details.
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